Bioxcel Therapeutics shares owned by Capital Investment Advisory Services
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Capital Investment Advisory Services
from 13F filings
Historical chart of Capital Investment Advisory Services investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Capital Investment Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Bioxcel Therapeutics by Capital Investment Advisory Services
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $50k | 18k | 2.82 |
2023-12-31 | $53k | 18k | 2.95 |
2023-09-30 | $46k | 18k | 2.53 |
2023-06-30 | $115k | 17k | 6.66 |
2023-03-31 | $323k | 17k | 18.66 |
2022-03-31 | $294k | 14k | 20.89 |
2021-12-31 | $286k | 14k | 20.32 |
2021-09-30 | $491k | 16k | 30.36 |
2021-06-30 | $477k | 16k | 29.04 |
2021-03-31 | $716k | 17k | 43.13 |
2020-12-31 | $730k | 16k | 46.20 |
2020-09-30 | $590k | 14k | 43.38 |
2020-06-30 | $705k | 13k | 53.01 |
2020-03-31 | $320k | 14k | 22.38 |
2019-09-30 | $35k | 5.0k | 7.00 |
2019-06-30 | $53k | 5.0k | 10.60 |
More positions owned by Capital Investment Advisory Services
View all positions for Capital Investment Advisory Services